US drug approvals
1 approvals with a product on the US market
- Endari NDA208587 · approved 7 Jul 2017
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
- 0Reports naming them
- 2Markets in public records
- 0Regions & countries
- See reportsGrowth in full reports
Free public data on Emmaus Medical
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on openFDA (opens in a new tab)
Markets where public records show them
Markets we cover where free public records show Emmaus Medical: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Emmaus Medical is in.
From our blog
Stories on the topics Emmaus Medical works in.
Women's Health Supplements: A Growing Focus
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Iron Supplements and the Fight Against Anaemia
Iron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is…
Read
Vitamin B12: The Deficiency Many People Miss
Vitamin B12 comes almost only from animal foods. Vegetarians, older adults and people on some medicines are…
Read